These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12030311)

  • 21. [Pathological aging of the brain. Personal observations on the use of citicoline].
    Palleschi M; Capobianco G
    Clin Ter; 1988 Apr; 125(2):121-8. PubMed ID: 2973933
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy and tolerability of a once daily formulation of Ginkgo biloba extract EGb 761® in Alzheimer's disease and vascular dementia: results from a randomised controlled trial.
    Ihl R; Tribanek M; Bachinskaya N;
    Pharmacopsychiatry; 2012 Mar; 45(2):41-6. PubMed ID: 22086747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuronal correlates of serial position performance in amnestic mild cognitive impairment.
    Kasper E; Brueggen K; Grothe MJ; Bruno D; Pomara N; Unterauer E; Duering M; Ewers M; Teipel S; Buerger K
    Neuropsychology; 2016 Nov; 30(8):906-914. PubMed ID: 27182709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation?
    Parnetti L; Mignini F; Tomassoni D; Traini E; Amenta F
    J Neurol Sci; 2007 Jun; 257(1-2):264-9. PubMed ID: 17331541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Verbal memory decline in Alzheimer's disease: a multiple-processes deficit.
    Pepin EP; Eslinger PJ
    Neurology; 1989 Nov; 39(11):1477-82. PubMed ID: 2812326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-cognitive benefits of galantamine (Reminyl) treatment in vascular dementia.
    Kurz A
    Acta Neurol Scand Suppl; 2002; 178():19-24. PubMed ID: 12492788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in the behavioral and psychological symptoms between Alzheimer's disease and vascular dementia: are the different pharmacologic treatment strategies justifiable?
    Kim JM; Lyons D; Shin IS; Yoon JS
    Hum Psychopharmacol; 2003 Apr; 18(3):215-20. PubMed ID: 12672174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT).
    Zafonte RD; Bagiella E; Ansel BM; Novack TA; Friedewald WT; Hesdorffer DC; Timmons SD; Jallo J; Eisenberg H; Hart T; Ricker JH; Diaz-Arrastia R; Merchant RE; Temkin NR; Melton S; Dikmen SS
    JAMA; 2012 Nov; 308(19):1993-2000. PubMed ID: 23168823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acetylcholinesterase inhibitors for vascular dementia and Alzheimer's disease combined with cerebrovascular disease.
    Bowler JV
    Stroke; 2003 Feb; 34(2):584-6. PubMed ID: 12574580
    [No Abstract]   [Full Text] [Related]  

  • 30. CDP-choline: pharmacological and clinical review.
    Secades JJ; Frontera G
    Methods Find Exp Clin Pharmacol; 1995 Oct; 17 Suppl B():1-54. PubMed ID: 8709678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term treatment with citicoline may improve poststroke vascular cognitive impairment.
    Alvarez-Sabín J; Ortega G; Jacas C; Santamarina E; Maisterra O; Ribo M; Molina C; Quintana M; Román GC
    Cerebrovasc Dis; 2013; 35(2):146-54. PubMed ID: 23406981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detecting dementia with the Hopkins Verbal Learning Test and the Mini-Mental State Examination.
    Kuslansky G; Katz M; Verghese J; Hall CB; Lapuerta P; LaRuffa G; Lipton RB
    Arch Clin Neuropsychol; 2004 Jan; 19(1):89-104. PubMed ID: 14670382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dementing disorders. What benefits do the new anti-dementia drugs have?].
    Ihl R
    MMW Fortschr Med; 2002 May; Suppl 2():24-6, 28-9. PubMed ID: 12070846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serial-position effects in paragraph recall following mild closed-head injury.
    Hall S; Bornstein RA
    Percept Mot Skills; 1991 Jun; 72(3 Pt 2):1295-8. PubMed ID: 1961678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serial position effects in dementia of the Alzheimer type.
    Burkart M; Heun R; Benkert O
    Dement Geriatr Cogn Disord; 1998; 9(3):130-6. PubMed ID: 9621999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy of prolonged therapy of vascular dementia].
    Klin Med (Mosk); 2011; 89(5):57-60. PubMed ID: 22242270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of mild cognitive impairment: value of citicoline].
    Abad-Santos F; Novalbos-Reina J; Gallego-Sandín S; García AG
    Rev Neurol; 2002 Oct 1-15; 35(7):675-82. PubMed ID: 12389156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly.
    Fioravanti M; Yanagi M
    Cochrane Database Syst Rev; 2000; (2):CD000269. PubMed ID: 10796523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Qualitative aspects of learning, recall, and recognition in dementia.
    Ranjith N; Mathuranath PS; Sharma G; Alexander A
    Ann Indian Acad Neurol; 2010 Apr; 13(2):117-22. PubMed ID: 20814495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholinesterase inhibitors for rarer dementias associated with neurological conditions.
    Li Y; Hai S; Zhou Y; Dong BR
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD009444. PubMed ID: 25734590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.